Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Sponsor: University of Texas Southwestern Medical Center
Summary
A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
Official title: Identifying Undiagnosed HFpEF Among Patients With Type 2 Diabetes Using Ultromics AI HFpEF Algorithm
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
800
Start Date
2025-08-06
Completion Date
2027-06-15
Last Updated
2025-08-12
Healthy Volunteers
No
Conditions
Interventions
Message with EchoGo
This alert will inform the provider that the patient has subclinical HFpEF
Standard Message
This alert will inform the provider of guideline directed treatment options for patients with diabetes to prevent heart failure.
Locations (1)
UT Southwestern Medical Center
Dallas, Texas, United States